Literature DB >> 1917793

L-tyrosine-binding proteins on melanoma cells.

A Slominski1.   

Abstract

Crosslinking of [14C]L-tyrosine to at least five hamster melanoma cell surface proteins is reported. This effect was abolished by addition of nonradioactive L-tyrosine, L-phenylalanine, or L-dopa, but not by D-tyrosine, tyramine, dopamine, norepinephrine, or epinephrine. The above proteins can be purified by tyrosine-affinity chromatography. They have molecular weights different from proteins staining for dopa oxidase and proteins that bind anti-tyrosinase antibody in Western blots. It is suggested that they may be a hithergo unrecognized part of the cellular apparatus governing melanogenesis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1917793     DOI: 10.1007/bf02633219

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol        ISSN: 0883-8364


  12 in total

1.  Biochemistry of melanin formation.

Authors:  A B LERNER; T B FITZPATRICK
Journal:  Physiol Rev       Date:  1950-01       Impact factor: 37.312

2.  L-tyrosine induces synthesis of melanogenesis related proteins.

Authors:  A Slominski
Journal:  Life Sci       Date:  1989       Impact factor: 5.037

3.  Isolation of a proteolytically derived domain of the insulin receptor containing the major site of cross-linking/binding.

Authors:  S M Waugh; E E DiBella; P F Pilch
Journal:  Biochemistry       Date:  1989-04-18       Impact factor: 3.162

4.  Differential expression and activity of melanogenesis-related proteins during induced hair growth in mice.

Authors:  A Slominski; R Paus; R Costantino
Journal:  J Invest Dermatol       Date:  1991-02       Impact factor: 8.551

5.  The biosynthesis of mammalian melanin.

Authors:  J M Pawelek; A M Körner
Journal:  Am Sci       Date:  1982 Mar-Apr       Impact factor: 0.548

6.  Purification of tyrosinase to homogeneity based on its resistance to sodium dodecyl sulfate-proteinase K digestion.

Authors:  E J Yurkow; J D Laskin
Journal:  Arch Biochem Biophys       Date:  1989-11-15       Impact factor: 4.013

7.  Are L-tyrosine and L-dopa hormone-like bioregulators?

Authors:  A Slominski; R Paus
Journal:  J Theor Biol       Date:  1990-03-08       Impact factor: 2.691

8.  Targeting of a lysosomal membrane protein: a tyrosine-containing endocytosis signal in the cytoplasmic tail of lysosomal acid phosphatase is necessary and sufficient for targeting to lysosomes.

Authors:  C Peters; M Braun; B Weber; M Wendland; B Schmidt; R Pohlmann; A Waheed; K von Figura
Journal:  EMBO J       Date:  1990-11       Impact factor: 11.598

9.  Positive regulation of melanin pigmentation by two key substrates of the melanogenic pathway, L-tyrosine and L-dopa.

Authors:  A Słominski; G Moellmann; E Kuklinska; A Bomirski; J Pawelek
Journal:  J Cell Sci       Date:  1988-03       Impact factor: 5.285

10.  MSH inhibits growth in a line of amelanotic hamster melanoma cells and induces increases in cyclic AMP levels and tyrosinase activity without inducing melanogenesis.

Authors:  A Slominski; G Moellmann; E Kuklinska
Journal:  J Cell Sci       Date:  1989-04       Impact factor: 5.285

View more
  3 in total

Review 1.  L-tyrosine and L-dihydroxyphenylalanine as hormone-like regulators of melanocyte functions.

Authors:  Andrzej Slominski; Michal A Zmijewski; John Pawelek
Journal:  Pigment Cell Melanoma Res       Date:  2011-09-02       Impact factor: 4.693

Review 2.  The Dark Side of Melanin Secretion in Cutaneous Melanoma Aggressiveness.

Authors:  Luís C Cabaço; Ana Tomás; Marta Pojo; Duarte C Barral
Journal:  Front Oncol       Date:  2022-05-10       Impact factor: 5.738

Review 3.  Transplantable Melanomas in Hamsters and Gerbils as Models for Human Melanoma. Sensitization in Melanoma Radiotherapy-From Animal Models to Clinical Trials.

Authors:  Martyna Śniegocka; Ewa Podgórska; Przemysław M Płonka; Martyna Elas; Bożena Romanowska-Dixon; Małgorzata Szczygieł; Michał A Żmijewski; Mirosława Cichorek; Anna Markiewicz; Anna A Brożyna; Andrzej T Słominski; Krystyna Urbańska
Journal:  Int J Mol Sci       Date:  2018-04-01       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.